Arvinas, Inc. (ARVN) vs Ovid Therapeutics (OVID)

Arvinas, Inc. and Ovid Therapeutics are both Biotechnology companies. Arvinas, Inc. and Ovid Therapeutics are of similar size ($509.4M and $487.3M). Ovid Therapeutics has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 58.3×. Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against −15.1%. Arvinas, Inc. has the higher net margin (2.94% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 18 metrics below, Arvinas, Inc. leads on 13 and Ovid Therapeutics on 5.

Valuation

Metric ARVN OVID Biotechnology median
P/E 58.31 n/m 7.88
P/S 1.55 60.33 11.47
P/B 0.87 2.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 4.20 n/m 0.74
EV/Sales (0.24) 46.84 10.73
Earnings yield 1.72% (9.39%) (28.84%)
Free cash flow yield (42.51%) (11.59%) (23.03%)

Profitability

Metric ARVN OVID Biotechnology median
Gross margin 97.16% 100.00% 65.16%
Operating margin (5.72%) (742.97%) 0.00%
Net margin 2.94% (439.11%) 0.00%
Free cash flow margin (65.93%) (697.30%) 0.00%
Return on equity 1.59% (25.97%) (57.72%)
Return on assets 1.17% (22.30%) (49.22%)
Return on invested capital 0.00% (35.11%) 0.00%

Growth

Metric ARVN OVID Biotechnology median
Revenue growth (TTM) (15.05%) 1,333.39% 5.64%
EPS growth (last fiscal year) 58.84% 37.84% —
Revenue growth, 5-year CAGR 58.93% (10.48%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARVN OVID Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 7.91 12.39 4.73
Net debt to EBITDA 5.62 1.37 0.96

Dividend

Metric ARVN OVID Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ARVN OVID Biotechnology median
Market cap 509.36m 487.27m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack